This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pereira-Chioccola, V L Articles by Kloetzel, J K Search for Related Content PubMed PubMed Citation Articles by Pereira-Chioccola, V L Articles by Kloetzel, J K

 Previous Article  |  Next Article 

Infection and Immunity, July 1994, p. 2973-2978, Vol. 62, No. 7
0019-9567/1994/$04.00+0     DOI:

research-article

Sera from chronic Chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain.

V L Pereira-Chioccola, S Schenkman, and J K Kloetzel

Laboratório de Xenodiagnóstico, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.

ABSTRACT

We investigated whether sera from chronic Chagasic patients and animals infected with Trypanosoma cruzi inhibit the removal of sialic acid from human erythrocytes and the transfer of sialic acid from sialyllactose to [14C]lactose in the reactions catalyzed by the parasite trans-sialidase. Sera from Swiss mice and Calomys callosus animals infected with three different T. cruzi strains inhibit both reactions. Inhibition increases during the infection, reaching maximal levels when the parasitemia decreases. Among 44 sera of untreated chronic Chagasic patients, 40 inhibit both reactions. Inhibition is observed with total, defatted sera or with purified immunoglobulins. Whereas most of the inhibitory antibodies from Chagasic patients react with the papain fragment of trans-sialidase in immunoblots, a few patients have noninhibitory antibodies that react only with the entire trans-sialidase. These findings may be relevant for the pathology of Chagas' disease.

---

Infection and Immunity, July 1994, p. 2973-2978, Vol. 62, No. 7
0019-9567/1994/$04.00+0     DOI:

This article has been cited by other articles:

• Pereira-Chioccola, V. L., Fragata-Filho, A. A., Levy, A. M. d. A., Rodrigues, M. M., Schenkman, S. (2003). Enzyme-Linked Immunoassay Using Recombinant trans-Sialidase of Trypanosoma cruzi Can Be Employed for Monitoring of Patients with Chagas' Disease after Drug Treatment. CVI 10: 826-830 [Abstract] [Full Text]  
• Pitcovsky, T. A., Mucci, J., Alvarez, P., Leguizamon, M. S., Burrone, O., Alzari, P. M., Campetella, O. (2001). Epitope Mapping of trans-Sialidase from Trypanosoma cruzi Reveals the Presence of Several Cross-Reactive Determinants. Infect. Immun. 69: 1869-1875 [Abstract] [Full Text]  
• Buchovsky, A. S., Campetella, O., Russomando, G., Franco, L., Oddone, R., Candia, N., Luquetti, A., Gonzalez Cappa, S. M., Leguizamon, M. S. (2001). trans-Sialidase Inhibition Assay, a Highly Sensitive and Specific Diagnostic Test for Chagas' Disease. CVI 8: 187-189 [Abstract] [Full Text]  
• Pereira-Chioccola, V., Acosta-Serrano, A, Correia de Almeida, I, Ferguson, M., Souto-Padron, T, Rodrigues, M., Travassos, L., Schenkman, S (2000). Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J. Cell Sci. 113: 1299-1307 [Abstract]  
• Leguizamón, M. S., Russomando, G., Rojas de Arias, A., Samudio, M., Cabral, M., González-Cappa, S. M., Frasch, A. C. C., Campetella, O. (1998). Use of trans-Sialidase Inhibition Assay in a Population Serologically Negative for Trypanosoma cruzi but at a High Risk of Infection. CVI 5: 254-255 [Abstract] [Full Text]